Real-world comorbidities and treatment patterns among patients with non-alcoholic fatty liver disease receiving phosphatidylcholine as adjunctive therapy in Russia

por Maev, Igor V, Samsonov, Aleksey A, Palgova, Liudmila K, Pavlov, Chavdar S, Shirokova, Elena, Starostin, Kirill M
Publicado 2019

Effectiveness of phosphatidylcholine in alleviating steatosis in patients with non-alcoholic fatty liver disease and cardiometabolic comorbidities (MANPOWER study)

por Maev, Igor V, Samsonov, Aleksey A, Palgova, Liudmila K, Pavlov, Chavdar S, Vovk, Elena I, Shirokova, Elena N, Starostin, Kirill M
Publicado 2020

Effectiveness of phosphatidylcholine as adjunctive therapy in improving liver function tests in patients with non-alcoholic fatty liver disease and metabolic comorbidities: real-li...

por Maev, Igor V, Samsonov, Aleksey A, Palgova, Liudmila K, Pavlov, Chavdar S, Shirokova, Elena N, Vovk, Elena I, Starostin, Kirill M
Publicado 2020

Correlation of Objective Endpoints and Subjective Patient-Reported Outcomes in NAFLD Treatment with Essential Phospholipids: Real-World Data Based on Pooled Analysis of Observation...

por Ivashkin, Vladimir T., Maevskaya, Marina V., Shirokova, Elena N., Maev, Igor V., Samsonov, Alexey A., Sas, Evgeniy I., Palgova, Liudmila K., Starostin, Kirill
Publicado 2021